[Special Stock] Alzheimer Early Diagnosis Related Stocks... PeopleBio Hits Upper Limit↑
PeopleBio, a company possessing technology related to the early diagnosis of Alzheimer's disease, has hit the upper price limit.
As of 2:05 PM on the 29th, PeopleBio is trading on the KOSDAQ market at 3,750 KRW, up 865 KRW (29.98%) from the previous day.
Founded in September 2002, PeopleBio is a company primarily engaged in pharmaceutical development using biotechnology, food ingredient development, chemical substance development and supply, and consulting.
The company's main product includes a blood test product that can be used for the early diagnosis of Alzheimer's disease, one of the representative degenerative brain diseases.
Hot Picks Today
"I Might End Up Paying My Entire Salary Just for Interest"... Annual Per-Person Interest Could Reach 6.73 Million Won, 'Yeongkeul-jok' Lament
- Gwangju Abuzz Over Choi Tae-won's Instagram Follow: "Chairman, Are You Craving Jeolla Cuisine?"
- "Will I Really Be Left Out If I Don't Use It?"... The App Used by 23 Million Koreans Monthly, Is Naver Feeling the Pressure?
- Jensen Huang: "SK hynix ADR Is Incredibly Successful"
- Amid Record Heatwave and 'Delivery Ban' Orders, Italian Riders Strike: "Die from Heat or Starve"
Currently, the Alzheimer's blood test under the AlzOn brand is being conducted at 120 medical institutions nationwide, including advanced general hospitals, health screening centers, and clinics.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
